Skip to main content
Caplight Logo









AARDEX Group

AARDEX Group

Private
SeraingHealthcare & Life Scienceshttps://aardexgroup.com/

Last Round

Series B

Oct 17, 2023

Company Overview

AARDEX Group is a healthcare technology company that provides digital solutions for measuring and managing medication adherence in clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medication adherenceclinical trial adherenceclinical trial data integritysmart packagingmedication event monitoringpatient adherence analyticsdecentralized clinical trialsDCTssmart pill bottleclinical trial technologysmart blister packClinTechpharma techhealth IoTCRO technologyhybrid clinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AARDEX Group Comparables

Compare AARDEX Group with similar companies based on industry and business-model similarity.

AARDEX Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Information Mediary Corp.
88%
Pill Connect Limited
83%
AiCure
82%

AARDEX Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 17, 2023
VC RoundMar 6, 2020

AARDEX Group Investors

Notable investors and investment history

AARDEX Group investors
InvestorRounds
NoshaqVC Round
Wallonie EntreprendreVC Round
Centre de Cautionnement et de Financement SAVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 17, 2023

    Led by medmix AG

  • Mar 6, 2020

    Raised capital from Noshaq, Wallonie Entreprendre, and Centre de Cautionnement et de Financement SA.

AARDEX Group Filings

Explore SEC and related filing metadata, where available.

AARDEX Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AARDEX Group's valuation, stock price, and market status.

Is AARDEX Group a public or private company?

AARDEX Group is a private company.

What is the current stock price of AARDEX Group?

AARDEX Group is a private company with no public stock price. No recent secondary market data is available.

How much is AARDEX Group worth (valuation)?

Valuation information for AARDEX Group is not publicly available.

Can I buy AARDEX Group stock?

AARDEX Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AARDEX Group's last funding round?

AARDEX Group's most recent funding round was Series B on October 17, 2023.

Who are the main investors in AARDEX Group?

Key investors in AARDEX Group include Noshaq, Wallonie Entreprendre, Centre de Cautionnement et de Financement SA.

Will AARDEX Group IPO soon?

No public IPO plans have been announced for AARDEX Group.

How can I track AARDEX Group secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AARDEX Group's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeraing
Year Founded1984
Last FundingOct 17, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?